Skip to content

Treatment of Periodontitis by Tulsi Gel

Non Surgical Treatment Using Tulsi Gel Versus Chlorhexidine Gel as Adjunctive in Treatment of Advanced Periodontitis ( Stage III and Stage IV )

Status
Not yet recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06675578
Enrollment
24
Registered
2024-11-05
Start date
2025-07-31
Completion date
2025-11-30
Last updated
2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Periodontitis, Stage III Periodontitis, Stage IV Periodontitis

Keywords

periodontitis, clinical attachment loss, advanced periodontitis

Brief summary

This study will be carried out to compare between the effect of 4%Tulsi gel and 1%Chlorohexidine gel as locally administered agents in the treatment of advanced periodontitis. Clinical parameters measurements, microbiological and radiographic assessment will be performed at base line, one month and 3 months after the intervention.

Interventions

DRUGTulsi gel

After scaling and root debridement, 4% of Tulsi gel will be injected in to the sulcus until it over flooded, at base line, then after one month.

After scaling and root debridement, 1% of Chlorhexidine gel will be injected in to the sulcus until it over flooded, at base line, then after one month.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* All patients included in this study will be having advancedI Periodontitis * Aging from 30 to 50 years old * Free from any local or systemic risk factors that may affect the results of the study.

Exclusion criteria

* Long-term therapy with medications within a month prior to enrollment that could affect periodontal status or healing. * Pregnant woman and lactating mothers. * Patients with previous periodontal treatment including scaling and root planning and periodontal surgery in the last 3 and 6 months, respectively.

Design outcomes

Primary

MeasureTime frameDescription
Clinical parameters3 months after end of treatmentImprovement of the clinical attachment loss in millimeters.

Secondary

MeasureTime frameDescription
Microbiological assessment3 months after end of treatmentCounting microbial colony of Porphyromonas gingivalis

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026